triazolam
Generic: triazolam
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
triazolam
Generic Name
triazolam
Labeler
mylan pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
triazolam .125 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59762-3717
Product ID
59762-3717_eb080fc0-b150-46ce-bf63-b09b47255a73
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA017892
DEA Schedule
civ
Listing Expiration
2027-12-31
Marketing Start
1982-11-15
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
597623717
Hyphenated Format
59762-3717
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
triazolam (source: ndc)
Generic Name
triazolam (source: ndc)
Application Number
NDA017892 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .125 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (59762-3717-9)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "eb080fc0-b150-46ce-bf63-b09b47255a73", "openfda": {"nui": ["N0000175694", "M0002356"], "upc": ["0359762371898", "0359762371799"], "unii": ["1HM943223R"], "rxcui": ["198317", "198318"], "spl_set_id": ["5add318e-11b9-42f8-b052-0d8cebb32fcf"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (59762-3717-9)", "package_ndc": "59762-3717-9", "marketing_start_date": "20170113"}], "brand_name": "Triazolam", "product_id": "59762-3717_eb080fc0-b150-46ce-bf63-b09b47255a73", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "59762-3717", "dea_schedule": "CIV", "generic_name": "triazolam", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triazolam", "active_ingredients": [{"name": "TRIAZOLAM", "strength": ".125 mg/1"}], "application_number": "NDA017892", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "19821115", "listing_expiration_date": "20271231"}